Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02747771

Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)

This study aims at evaluating the effectiveness of group-based cognitive behavioral therapy for trichotillomania at three clinical sites in Norway.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–67 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Oslo University Hospital

Oslo, 0607, Norway

Location status: Recruiting

Location contact

Benjamin Hummelen, PhD

CONTACT

[email protected]

+4795741039

About this study

The Norwegian Trichotillomania Project is a multicenter study that aims at evaluating the effectiveness of behavioral group therapy for TTM, i.e., ACT (Acceptance and commitment therapy) enhanced habit reversal training (ACT-enhanced HRT).

Participants are adults or adolescents (16 year or older) who fulfill criteria for TTM according to DSM-IV. Inclusion started in January 2013 and will be completed by Mai 2016. Treatment is delivered at three treatment sites in Norway; in Kristiansand, Oslo, and Trondheim. Treatment is manualized, following the manual of Twohig and Woods, and consists of ten group sessions of three hours delivered at consecutive weeks, and two or three booster sessions during the first year after treatment.

Treatment outcome is evaluated by three outcome measures; the Massachusetts General Hospital - Hairpulling Scale (self-report); the National Institute of Mental Health Trichotillomania Severity Scale (clinical interview, conducted by independent evaluators); and the Clinical Global Impression Scale for TTM. Outcome is measured at three points in time; at baseline, at the end of treatment, and at one-year follow-up. Mixed models procedures in SPSS is used to analyze longitudinal data.

The first paper will be written on patients admitted to treatment from January 2013 to September 2014, and includes 53 patients (49 women and four men). By January 2016, fifty-one patients (96%) had participated in the one-year follow-up evaluation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria:
  • Clinical diagnosis of Trichotillomania
  • Age between 16 and 67
  • Exclusion Criteria:
  • schizophrenia spectrum disorder
  • substance addiction
  • severe antisocial, schizotypal, or paranoid personality disorder
  • severe eating disorder,
  • ongoing suicidal ideation
  • pervasive developmental disorder
  • mental retardation and severe sequelae after brain injury.

Treatment and study plan

Cognitive behavioral therapy

Behavioral

10 sessions Group therapy during 10-12 weeks. The first three sessions focus on habit reversal training, the fourth to sixth session on acceptance and commitment therapy and the last four sessions aims at integrating the two approaches.

Other names: Acceptance and commitment therapy (ACT), Habit reversal training (HRT)

Primary outcomes

  1. Change in National Institute of Mental Health Trichotillomania Severity Scale (NIMH-TSS)

    Time frame: baseline, 12 weeks, 12 months

    clinical interview

  2. Change in Massachusetts General Hospital - Hairpulling Scale (MGH-HS)

    Time frame: baseline, 12 weeks, 12 months

    self-report

Secondary outcomes

  1. Change Patient Health Questionnaire-9 (PHQ-9)

    Time frame: baseline, 12 weeks, 12 months

    self-report depressive symptoms

  2. Change General Anxiety Disorder Scale (GAD-7)

    Time frame: baseline, 12 weeks, 12 months

    self-report anxiety symptoms

  3. Change Metacognition Questionnaire (MCQ-30)

    Time frame: baseline, 12 weeks, 12 months

    self-reported metacognitions

  4. Change in Acceptance and Action Questionnaire for Trichotillomania

    Time frame: baseline, 12 weeks, 12 months

    self-report

Study contacts

Contact information is provided by the study sponsor or research team.

Benjamin Hummelen, Ph.D., M.D.

CONTACT

[email protected]

+4795741039

Erna M Moen, Master

CONTACT

[email protected]

+4722118080

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Sorlandet Hospital HF
  • St. Olavs Hospital
  • Texas A&M University
  • University of Michigan

Registry information

Official study title

The Norwegian Trichotillomania Project

Acronym: NorTriP

Important dates

Study start
2013
Primary completion
2024
Study completion
2026
First posted
Apr 22, 2016
Registry last updated
Mar 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.